Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner

Molecular Medicine Reports

Volumn 11, Issue 2, 2015, Pages 783-790

  Shen, Mo ^a   Duan, Xiuzhi ^b   Zhou, Ping ^c   Zhou, Wu ^a   Wu, Xiuling ^a   Xu, Siqi ^a   Chen, Yuhua ^b   Tao, Zhihua ^b  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Wenzhou WuMa Community Health Service Center   (China)

Author keywords

Bladder cancer; Lymphotoxin receptor; Nf B pathway

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN BETA RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

AGED; BLADDER; BLADDER TUMOR; CANCER STAGING; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOTOXIN BETA RECEPTOR; MALE; MIDDLE AGED; NEOPLASM STAGING; NF-KAPPA B; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84916219853     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2826     Document Type: Article

References (28)

1. American Cancer Society: Cancer Facts and Figures 2011. American Cancer Society, Atlanta, GA, 2011.
2. Ben Selma W, Ziadi S, Ben Gacem R, Amara K, Ksiaa F, Hachana M and Trimeche M: Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract 206: 740-743, 2010.
3. Dobrovolskaia MA and Kozlov SV: Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets 5: 325-344, 2005.
4. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
5. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
6. Kuper H, Adami HO and Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med 248: 171-183, 2000.
7. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
8. Hold GL and El-Omar EM: Genetic aspects of inflammation and cancer. Biochem J 410: 225-235, 2008.
9. Wolf MJ, Seleznik GM, Zeller N and Heikenwalder M: The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene 29: 5006-5018, 2010.
10. Lukashev M, LePage D, Wilson C, et al: Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res 66: 9617-9624, 2006.
11. Haybaeck J, Zeller N, Wolf MJ, et al: A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16: 295-308, 2009.
12. Zhou P, Fang X, McNally BA, et al: Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition. Proc Natl Acad Sci USA 106: 17134-17139, 2009.
13. Ammirante M, Luo JL, Grivennikov S, Nedospasov S and Karin M: B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464: 302-305, 2010.
14. Dhawan P, Su Y, Thu YM, Yu Y, Baugher P, Ellis DL, Sobolik-Delmaire T, Kelley M, Cheung TC, Ware CF and Richmond A: The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J Biol Chem 283: 15399-15408, 2008.
15. Lan J, Heneghan AF, Sano Y, Jonker MA, Omata J, Xu W, Pierre JF and Kudsk KA: Parenteral nutrition impairs lymphotoxin β receptor signaling via NF-κB. Ann Surg 253: 996-1003, 2011.
16. Xu Y, Zhang C, Wang N, Ling F, Li P, Gao Y and Hua W: Adiponectin inhibits lymphotoxin-β receptor-mediated NF-κB signaling in human umbilical vein endothelial cells. Biochem Biophys Res Commun 404: 1060-1064, 2011.
17. Daller B, Müsch W, Röhrl J, Tumanov AV, Nedospasov SA, Männel DN, Schneider-Brachert W and Hehlgans T: Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner. Int J Cancer 128: 1363-1370, 2011.
18. Hunter MJ, Treharne KJ, Winter AK, Cassidy DM, Land S and Mehta A: Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling. PLoS One 5: e11598, 2010.
19. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
20. MostofiFK, Sobin LH and Torloni H; World Health Organization: Histological typing of urinary bladder tumours. In: International Histological Classification of Tumours, No 10. World Health Organization, Geneva, 1973.
21. Sauter G, Algaba F, Amin MB, Busch C, Cheville J, Gasser T, Grignon D, Hofstaedter F, Lopez-Beltran A and Epstein JI: Non-invasive urothelial tumours. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JI and Sesterhenn IA (eds). IARC Press, Lyon, p110, 2004.
22. Sobin DH and Witteking CH (eds): TNM Classification of Malignant Tumours. 6th edition. Wiley-Liss, New York, pp199-202, 2002.
23. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
24. Colotta F, Allavena P, Sica A, Garlanda C and Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081, 2009.
25. Sakurai H, Chiba H, Miyoshi H, Sugita T and Toriumi W: IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356, 1999.
26. O'Mahony AM, Montano M, Van Beneden K, Chen LF and Greene WC: Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65. J Biol Chem 279: 18137-18145, 2004.
27. Müller JR and Siebenlist U: Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 278: 12006-12012, 2003.
28. Pomerantz JL and Baltimore D: Two pathways to NF-kappaB. Mol Cell 10: 693-695, 2002.